Displaying archives for November 2018 - ALCMI - Addario Lung Cancer Medical Institute:

Patients Launch New Study to Shed Light on EGFR-Positive Lung Cancers

Posted by Bradley Newton on November 15th, 2018 |

The Addario Lung Cancer Medical Institute (ALCMI), Champions Oncology and EGFR Resisters today announced the launch of a new study to create a novel bank of patient derived xenograft (PDX) models to help researchers better understand why patients living with epidermal growth factor receptor (EGFR) positive lung cancer develop resistance to treatment over time, or […]